News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|June 15, 2012

Webinar Skin Disorders Multiplayer

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com

Doxecitine/doxribtimine cuts mortality risk in early-onset TK2d, new data show

ByBenjamin P. Saylor

June 17th 2026

Recognizing and managing allergic skin conditions across pediatric populations | Image Credit: © stopabox - stock.adobe.com

Recognizing and managing allergic skin conditions across pediatric populations

ByMike Hennessy Jr, President and CEO

June 17th 2026

$Journal Club: Ultrasound is not reliable for diagnosing ankle fractures$

Journal Club: Ultrasound is not reliable for diagnosing ankle fractures

ByMarian Freedman,Jon Matthew Farber, MD

June 17th 2026

Vosoritide data support planned FDA submission for hypochondroplasia | Image Credit: © Scott Cornell- stock.adobe.com.

Vosoritide data support planned FDA submission for hypochondroplasia

ByMorgan Ebert, Executive Editor

June 16th 2026

pCPA receives FDA Orphan Drug Designation for monoamine oxidase deficiency

pCPA receives FDA Orphan Drug Designation for monoamine oxidase deficiency

ByMorgan Ebert, Executive Editor

June 16th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Chronicity, Symptom Variability, and Treatment Expectations in Pediatric Functional Constipation and IBS-C

FDA issues Warning Letter to SNOO Smart Sleeper maker over unauthorized sleep sacks, hospital bundle, and quality system failures

Vosoritide data support planned FDA submission for hypochondroplasia

Doxecitine/doxribtimine cuts mortality risk in early-onset TK2d, new data show

Recognizing and managing allergic skin conditions across pediatric populations